PREVIOUS QUESTION:

 

NEXT QUESTION:

 

Which diabetes medicines are SGLT2 inhibitors?

ANSWER

SGLT2 inhibitors include:

These medications help your kidneys get rid of extra glucose by removing it from your blood and putting it into your urine.

  • Canagliflozin (Invokana)
  • Dapagliflozin (Farxiga)
  • Empagliflozin (Jardiance)

From: Treatment Options for Diabetes WebMD Medical Reference

SOURCES:

American Diabetes Association: “What Are My Options?” “What About Insulin?” “Insulin Basics.”

FDA: "FDA approves Afrezza to treat diabetes."

Joslin Diabetes Center: “Common Questions About Type 2 Diabetes.”

MedlinePlus: “Drug Information: Insulin Human (rDNA Origin) Inhalation.”

National Institute of Diabetes and Digestive and Kidney Diseases: “What I Need to Know About Diabetes Medicines.”

Scott Isaacs, MD, Atlanta Endocrine Associates.

Reviewed by Jennifer Robinson on January 11, 2018

SOURCES:

American Diabetes Association: “What Are My Options?” “What About Insulin?” “Insulin Basics.”

FDA: "FDA approves Afrezza to treat diabetes."

Joslin Diabetes Center: “Common Questions About Type 2 Diabetes.”

MedlinePlus: “Drug Information: Insulin Human (rDNA Origin) Inhalation.”

National Institute of Diabetes and Digestive and Kidney Diseases: “What I Need to Know About Diabetes Medicines.”

Scott Isaacs, MD, Atlanta Endocrine Associates.

Reviewed by Jennifer Robinson on January 11, 2018

NEXT QUESTION:

Which diabetes medicines are sulfonylureas?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.